| abstract |
The present invention relates to a fever medicine containing a Stauntonia hexaphylla leaf extract as an active ingredient. The Stuantonia hexaphylla leaf extract according to the present invention does not have cytotoxicity, and is completed by verifying a superior fever alleviation effect even when compared to existing fever medicines having fever alleviation effects. The composition for alleviating fever containing the Stauntonia hexaphylla leaf extract as the active ingredient has an excellent fever alleviation effect. |